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ABSTRACT
OBJECTIVE: Sciatic nerve neuropathy can be observed following intramuscular gluteal injections. The histopathological 
examination of sciatic nerve damage following intramuscular injection in the gluteal region for acute pain treatment is not 
feasible in humans due to the inability to dissect and examine the nerve tissue. To overcome this issue, we used a rat model 
for demonstrating damage to the sciatic nerve tissue after the application of commonly used drug injections.
METHODS: We investigated possible damage following the intramuscular injection of diclofenac, lornoxicam, morphine, and 
pethidine in a rat model based on histopathological characteristics such as myelin degeneration, axon degeneration, epineurium 
degeneration, fibrosis, epineurium thickening, perineurium thickening, lymphocyte infiltration, vacuolization, and edema.
RESULTS: All the analgesic drugs used in our study induced histopathological changes in the sciatic nerve. Anti-S100 
positivity, showing nerve damage, was found to be the lowest in the group treated with diclofenac. Neurotoxic effects of 
diclofenac on the sciatic nerve were greater than those of the other drugs used in the study. Lornoxicam induced the least 
histopathological changes in the nerve.
CONCLUSION: Diclofenac induced severe nerve damage not only after direct injection in the sciatic nerve but also after in-
jection in the area around the nerve. Thus, we recommend restricting the use of intramuscular gluteal injections of diclofenac. 
Intramuscular use of morphine and pethidine should also be overviewed.
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Sciatic nerve injury following analgesic drug 
injection in rats: A histopathological examination 
Orıgınal Article   NEUROLOGY
Intramuscular drug injection is preferred over oral drug administration in patients with pain complaints due to 
its observed immediate effects. Intramuscular drug ad-
ministration is usually performed in the gluteal region [1, 
2]. Even if the correct site, the correct method, a suitable 
injector, and an ideal dose are selected, sciatic nerve neu-
ropathy can be observed following intramuscular gluteal 
injections. The composition of the drug, the selection of 
an unsuitable injection site, unsterile conditions, the use 
of inappropriate tools, the level of technical skills and 
ability of the medical staff, as well as the condition of the 
patient may contribute to the undesirable results. In de-
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veloping countries lacking adequate healthcare facilities, 
the risk of sciatic nerve neuropathy after an intramuscu-
lar injection is higher [3–5]. The drugs most commonly 
causing sciatic neuropathy via the intramuscular route 
are antibiotics and analgesics [5, 6].
The histopathological examination of sciatic nerve 
damage following intramuscular injection in the gluteal 
region for acute pain treatment is not feasible in humans 
due to the inability to dissect and examine the nerve tis-
sue. In this study, we compared the pathological effects of 
intramuscular drugs commonly used in medical practice, 
including diclofenac, lornoxicam, morphine, and pethi-
dine, on the sciatic nerve in a rat model. In this animal 
model, the histopathological effects depending on the 
drug type and the selection of injection site were com-
pared.
MATERIALS AND METHODS
Histopathological changes in the sciatic nerve can be 
identified by examining the nerve tissue, and sciatic nerve 
damage can be easily shown in a rat model. In this study, 
we investigated possible damage following the intramus-
cular injection of diclofenac, lornoxicam, morphine, and 
pethidine for acute pain treatment in a rat model. The 
histopathological characteristics evaluated for the assess-
ment of the neural defect included myelin degeneration, 
axon degeneration, epineurium degeneration, fibrosis, 
epineurium thickening, perineurium thickening, lym-
phocyte infiltration, vacuolization, and edema. The study 
was conducted at the Istanbul Bagcilar Education and 
Research Hospital Animal Laboratory Section between 
June 1, 2013 and June 1, 2014.
In this study, 50 male Sprague Dawley rats (weigh-
ing 180–200 g) were used. All animals were fed with 
7–8 mm rat chow pellets ad libitum and water. White 
fluorescent light controlled with automated photoperiod 
was used to provide a 12-h light and 12-h dark environ-
ment, and ambient temperature and humidity were set 
at 21°C±2°C and 55%–60%, respectively. The meth-
ods used for animal experiments were adjusted accord-
ing to the protocols of the National Institute of Health 
Guide for the Care and Use of Laboratory Animals. The 
necessary permissions were obtained from the Local 
Ethics Committee for Animal Experiments of the Istan-
bul Bagcilar Education and Research Hospital (Date: 
12.27.2012, Issue no: 63). In total, 10 groups of animals, 
including control (saline) and drug-treated groups, each 
containing five subjects were evaluated.
The administered drugs, drug administration route, 
and drug doses were as follows [7–10]: 
Diclofenac injection in the sciatic nerve, 2 mg/kg/ 0.5 ml; 
Lornoxicam injection in the sciatic nerve, 1.3 mg/kg/0.5 ml; 
Morphine injection in the sciatic nerve, 0.2 mg/kg/0.5 ml; 
Pethidine injection in the sciatic nerve, 3 mg/kg/0.5 ml; 
Diclofenac injection in the surrounding muscle tissue of 
the sciatic nerve, 2 mg/kg/0.5 ml; 
Lornoxicam injection in the surrounding muscle tissue 
of the sciatic nerve, 1.3 mg/kg/0.5 ml;
Morphine injection in the surrounding muscle tissue of 
the sciatic nerve, 0.2 mg/kg/0.5 ml; 
Pethidine injection in the surrounding muscle tissue of 
the sciatic nerve, 3 mg/kg/0.5 ml;
Saline (a mixture of sodium chloride in water) injection 
in the sciatic nerve, 0.5 ml; and
Saline injection in the surrounding muscle tissue of the 
sciatic nerve, 0.5 ml.
The rats were anesthetized with ketamine and xy-
lazine. Thereafter, the sciatic nerve was exposed after dis-
secting through the gluteal muscles. The analgesics and 
saline were injected in the sciatic nerve and the muscles 
adjacent to the sciatic nerve. Subsequently, the gluteal 
muscles and skin tissues were sutured. After this, the 
rats were kept for 7 days in cages. Later, all the animals 
were decapitated under deep anesthesia with sodium 
pentothal (50–60 mg/kg), and the sciatic nerves were 
removed. The removed sciatic nerve tissues were used for 
histopathological and immunohistochemical examina-
tion, and the samples were stained within 24 h.
For staining, the labeled sciatic nerve tissues were 
fixed in 10% neutral buffered formalin. After keeping for 
24 h in the fixative, the samples were washed for about 
6–8 h in running water, following which the tissue track-
ing and processing were performed using an automatic 
device (Citadel 2000, Thermo Fisher Scientific Shan-
don, England) passing the samples through ethanol–xy-
lene series. Later, the samples were embedded in liquid 
paraffin. The tissues were sectioned 4–6-μm thick for 
routine hematoxylin–eosin staining and 3–4-μm thick 
for immunohistochemical staining. The cut sections for 
immunohistochemical staining were incubated for 20 
min in xylene and kept in 3% H2O2 solution for 10 min 
after passing through the series of alcohol (70%–99%). 
After washing with PBS, the sections were heated in the 
citrate buffer solution for 5–10 min at 600–800 W; they 
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groups. The results were evaluated at 95% confidence in-
terval and at p<0.05 level of significance.
RESULTS 
Histopathological results
On evaluating the damage after drug injection in the sci-
atic nerve, axon and myelin degeneration was observed 
to be greater in the diclofenac group (Table 1). In the 
epineurium of the nerve, moderate cell degeneration and 
edema were detected (Figure 1C, D). In the lornoxicam 
group, nerve fascicular structures comprising myelinated 
and non-myelinated nerve fibers were shown to preserve 
their round morphology with distinct borders. In the mor-
were allowed to stand for 10 min in the secondary block-
ing agent. Each slide was held for 60–75 min in various 
dilutions (1/100–1/300) of the primary antibody (An-
ti-S100-Coder: ab66041, Abcam plc, Cambridge CB4 
0FL UK). Diaminobenzidine (DAB) solution was used 
as the chromogen, and Mayer’s hematoxylin was used for 
counterstaining. PBS was used for negative controls.
After 1 month, the samples were examined within 
the same day. The appropriate slide regions under the 
light microscope were examined at different magnifica-
tions, and their pictures were taken. The blind reading 
and grading of slides were made by two histologists and 
by a pathologist. The positivity according to the percent-
age values was categorized in four grading categories: 
mild (+), moderate (++), severe (+++), and very severe 
(++++). The histopathological findings such as myelin 
degeneration, axon degeneration, epineurium degen-
eration, fibrosis, epineurium thickening, perineurium 
thickening, lymphocytic infiltration, vacuolization, and 
edema were evaluated. Additionally, these histopatho-
logical findings were divided into four grading categories 
according to the positivity for anti-S100: mild (+), mod-
erate (++), severe (+++), and very severe (++++). 
The observed histopathological findings in the groups 
with drug injections in the sciatic nerve were statistically 
compared with those in the control groups with saline 
injections in the sciatic nerve (Table 1). The observed 
histopathological findings in the groups with drug injec-
tions in the muscles adjacent to the sciatic nerve were sta-
tistically compared with those in the control groups with 
saline injections in the muscles adjacent to the sciatic 
nerve (Table 2). The groups with injections in the sciatic 
nerve and the ones with injections in the muscles adja-
cent to the sciatic nerve were also statistically compared 
with each other in terms of histopathological findings for 
each drug (Table 3). 
The groups with drug injections in the sciatic nerve 
were statistically compared with the control groups with 
saline injections in the sciatic nerve in terms of anti-S100 
positivity.
Statistical analysis 
The statistical analysis and assessment of the study find-
ings were performed using Number Cruncher Statisti-
cal System 2007 and Power Analysis and Sample Size 
2008 Statistical Software (NCSS LLC, Kaysville, Utah, 
USA). Mann–Whitney U test was used for compar-
isons of abnormally distributed parameters between the 
Figure 1. (A, B) Histopathological changes after injection 
in the muscle tissue adjacent to the sciatic nerve: epi, 
epineurium; e, edema; v, vacuolization; l, lymphocyte infil-
tration; star, normal axons; arrow head, degenerated axons; 
s, swollen Schwann cells; thick arrow, myelin degeneration; 
hematoxylin–eosin staining, ×40. (C, D) Histopathological 
changes after injection in the sciatic nerve: epi, epineurium; 
e, edema; v, vacuolization; l, lymphocyte infiltration; star, 
normal axons; arrow head, degenerated axons; s, swollen 
Schwann cells; thick arrow, myelin degeneration; hema-
toxylin–eosin staining, ×40. Control: star, normal axons; 
arrow head, mildly degenerated axons; s, normal Schwann 
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the epineurium was increased and both edema and degen-
eration were observed in the pethidine group (Fig. 1C, D).
In group where saline was injected in the sciatic nerve, 
swelling surrounding the axons of some nerve fibers, for-
mation of degenerated regions in the myelin sheaths, sepa-
ration of the lamellae of myelin from each other, and mild 
degeneration of axons in some nerve fibers were detected, 
but significant number of myelinated nerve fibers pre-
sented with normal morphological features (Fig. 1, Con-
trol). In the group where saline was injected adjacent to 
the sciatic nerve group, no histopathological changes were 
observed on the examination of the sciatic nerves using 
light microscopy. 
Immunohistochemical results
Immunohistochemical staining performed using the im-
munoperoxidase method in the groups in which injections 
were performed in the sciatic nerve yielded the following 
results for anti-S immunopositivity: (+) 60% and (++) 
40% in the diclofenac group; (++) 60% and (+++) 40% 
in the lornoxicam group; (+) 40%, (++) 40%, and (+++) 
20% in the morphine group; and (++) 20% and (+++) 
40% in the pethidine group(+++). Furthermore, anti-S 
immunopositivity was (+++) 40% and (++++) 60% in 
the saline group (Fig. 2A–D-Control).
Statistical Findings
Myelin degeneration
Myelin degeneration was found to be significantly higher 
in the groups in which drugs were injected directly in the 
sciatic nerve than in the groups in which saline was in-
jected (p<0.05) (Table 1). Furthermore, myelin degenera-
tion was significantly greater in the groups in which drugs 
(except pethidine) were injected around the sciatic nerve 
than in the groups in which saline was injected around 
the sciatic nerve (p<0.05) (Table 2). In the diclofenac and 
pethidine groups, myelin degeneration was shown to be 
significantly higher than that in the diclofenac and pethi-
dine groups in which drugs were injected in the tissue ad-
jacent to the sciatic nerve (p<0.05) (Table 3).
Axon degeneration
In the diclofenac and pethidine groups, axon degeneration 
was found to be significantly higher than that in the group 
in which saline was injected directly in the sciatic nerve 
(p<0.05) (Table 1). The axon degeneration with the in-
jection of any drug except pethidine in the tissue adjacent 
phine group, axon and myelin degeneration was present 
at a certain rate around the epineurium. In the pethidine 
group, axon and myelin degeneration was observed. The 
degenerated regions between the epineurium and en-
doneurium showed a gradual increase.
On evaluating the samples where drug was injected in 
the tissue adjacent to the sciatic nerve, axon degeneration, 
abundant lymphocyte infiltration, edema and vacuoliza-
tion, and thickening at perineural areas, fibrosis, and gran-
ulation tissue formation at injection sites were observed in 
the diclofenac group. Inflammation around the axons and 
mild degeneration of the myelin sheath were observed in 
the lornoxicam group. In the muscles, vacuolization areas 
increased but lacked a homogeneous distribution through-
out (Fig. 1A, B). In the morphine group, dense edema, 
vacuolization, fibrosis, and granulation tissue formation 
were observed (Fig. 1A, B). Myelin degeneration around 
Figure 2. (A, B) Histopathological changes after injection in 
the muscle tissue adjacent to the sciatic nerve detected us-
ing anti-S100 immunohistochemical staining: arrow head, 
degenerated axons; s, swollen Schwann cells; short arrow, 
immunopositive cells; v, vacuolization; immunoperoxidase 
staining. (C, D) Histopathological changes after injection 
in the sciatic nerve detected using anti-S100 immunohis-
tochemical staining: arrow head, degenerated axons; s, 
swollen Schwann cells; short arrow, immunopositive cells; 
v, vacuolization; epi, epineurium; e, edema; immunoper-
oxidase staining. Control: star, normal axons; short arrow, 








Pathological   ASaline (n) BMorphine (n) CPethidine (n) DDiclofenac (n) ELornoxicam (n) p
Changes Level
Myelin degeneration None 1 0 0 0 0 
    +1 3 0 0 0 0 A-B p=0.016*
    +2 1 3 1 0 4 A-C p=0.010*
    +3 0 2 2 2 1 A-D p=0.007**
    +4 0 0 2 3 0 A-E p=0.018*
Median (Min-Max)  1 (0-2) 2 (2-3) 3 (2-4) 4 (3-4) 2 (2-3) 
Axon degeneration None 1 0 0 0 0 
    +1 3 2 0 0 2 A-B p=0.090
    +2 1 0 0 0 1 A-C p=0.006**
    +3 0 3 4 2 2 A-D p=0.007**
    +4 0 0 1 3 0 A-E p=0.116
Median (Min-Max)  1 (0-2) 3 (1-3) 3 (3-4) 4 (3-4) 2 (1-3) 
Epineurium degeneration None 0 0 0 0 0 
    +1 4 3 1 0 1 A-B p=0.513
    +2 1 2 3 1 4 A-C p=0.065
    +3 0 0 1 4 0 A-D p=0.007**
Median (Min-Max)  1 (1-2) 1 (1-2) 2 (1-3) 3 (2-3) 2 (1-2) A-E p=0.072
Fibrosis 
    None 3 0 0 0 0 A-B p=0.006**
    +1 2 0 0 0 1 A-C p=0.006**
    +2 0 4 1 1 3 A-D p=0.006**
    +3 0 1 4 4 1 A-E p=0.013*
Median (Min-Max)  0 (0-1) 2 (2-3) 3 (2-3) 3 (2-3) 2 (1-3) 
Epineurium thickening None 3 0 0 0 0 A-B p=0.048*
    +1 2 5 0 0 2 A-C p=0.007**
    +2 0 0 3 2 3 A-D p=0.007**
    +3 0 0 2 3 0 A-E p=0.020*
Median (Min-Max)  0 (0-1) 1 (1-1) 2 (2-3) 3 (2-3) 2 (1-2) 
Perineurium thickening 
    None 0 0 0 0 0 A-B p=0.513
    +1 4 3 1 0 2 A-C p=0.054
    +2 1 2 2 5 3 A-D p=0.014*
    +3 0 0 2 0 0 A-E p=0.221
Median (Min-Max)  1 (1-2) 1 (1-2) 2 (1-3) 2 (2-2) 2 (1-2) 
Lymphocyte infiltration None 0 0 0 0 0 
    +1 4 0 0 0 0 A-B p=0.006**
    +2 1 0 0 0 4 A-C p=0.006**
    +3 0 3 3 0 1 A-D p=0.004**
    +4 0 2 2 5 0 A-E p=0.015*
Median (Min-Max)  1 (1-2) 3 (3-4) 3 (3-4) 4 (4-4) 2 (2-3) 
Vacuolisation None 0 0 0 0 0 
    +1 2 0 0 0 1 A-B p=0.093
    +2 3 4 2 0 2 A-C p=0.033*
    +3 0 1 1 1 1 A-D p=0.006**
    +4 0 0 2 4 1 A-E p=0.214
Table 1. The assessment of histopathological damage comparing saline with other drugs when the agents were injected in 
the sciatic nerve
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to the sciatic nerve was significantly higher than that with 
the injection of saline in the tissue adjacent to the sciatic 
nerve (p<0.05) (Table 2). Similar to myelin degeneration 
results, axon degeneration was found to be significantly 
higher in the diclofenac and pethidine groups in which 
the drugs were injected directly in the sciatic nerve than in 
those in which the drugs were injected in the tissue adja-
cent to the sciatic nerve (p<0.05) (Table 3).
Epineurium degeneration
Epineurium degeneration in the diclofenac group 
was significantly higher than that in the saline group 
(p<0.05) (Table 1). The degeneration was found to be 
significantly higher with the injection of any drug in the 
tissue adjacent to the sciatic nerve than with the injec-
tion of saline in the tissue adjacent to the sciatic nerve 
(p<0.05) (Table 2). Even epineurium degeneration was 
found to be greater in the group in which saline was di-
rectly injected in the sciatic nerve than in the group in 
which saline was injected in the tissue adjacent to the sci-
atic nerve (p<0.05) (Table 3).
Fibrosis
In comparison with saline, all drugs injected directly in the 
sciatic nerve resulted in a greater level of fibrosis (p<0.05) 
(Table 1). Similar findings were observed in the groups in 
which injection was performed in the tissue adjacent to 
the sciatic nerve (p<0.05) (Table 2). Greater fibrosis was 
observed in the groups in which morphine and pethidine 
were injected directly in the nerve than in those in which 
morphine and pethidine were injected in the tissue adja-
cent to the sciatic nerve (p<0.05) (Table 3). 
Epineurium thickening
Compared with saline, all drugs injected directly in the 
sciatic nerve resulted in greater epineurium thickening 
(p<0.05) (Table 1). Similar findings were observed in the 
groups in which injection was performed in the tissue ad-
jacent to the sciatic nerve (p<0.05) (Table 2). Saline in-
jected directly in the sciatic nerve caused more epineurium 
problems compared with that injected in the tissue adja-
cent to the nerve (p<0.05) (Table 3).
Perineurium thickening
Although any type of diclofenac injection resulted in 
greater perineurium thickening, lornoxicam injection in 
the area adjacent to the sciatic nerve resulted in greater 
perineurium thickening compared with saline injection 
(p<0.05) (Table 1 and 2). Perineurium thickening was 
greater in the groups in which pethidine and saline were 
directly injected in the sciatic nerve than in those in which 
pethidine and saline were injected in the tissue adjacent to 
the sciatic nerve (p<0.05) (Table 3).
Lymphocyte infiltration
Lymphocyte infiltration in all the groups in which drugs 
were directly injected in the sciatic nerve was signifi-
cantly higher than that in the groups in which saline was 
injected (p<0.05) (Table 1). On comparing the different 
drugs injected in the tissue adjacent to the sciatic nerve, 
the diclofenac and lornoxicam groups showed higher 
lymphocyte infiltration than the saline-injected groups 
(p<0.05) (Table 2). The injections of diclofenac, mor-
phine, or pethidine in the sciatic nerve caused higher 
lymphocyte infiltration than those in the tissue adjacent 
to the sciatic nerve (p<0.05) (Table 3).
Table 1. CONT.
Pathological   ASaline (n) BMorphine (n) CPethidine (n) DDiclofenac (n) ELornoxicam (n) p
Changes Level
Median (Min-Max)  2 (1-2) 2 (2-3) 3 (2-4) 4 (3-4) 2 (1-4) 
Edema None 1 0 0 0 0 
   +1 3 0 0 0 0 A-B p=0.005**
   +2 1 0 2 0 2 A-C p=0.013*
   +3 0 0 2 0 2 A-D p=0.005**
   +4 0 5 1 5 1 A-E p=0.013*
Median (Min-Max)  1 (0-2) 4 (4-4) 3 (2-4) 4 (4-4) 3 (2-4)
n: number of subjects with pathological changes, Mann Whitney U test; * p<0.05 **p<0.01.
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Vacuolization
Vacuolization was significantly higher in the diclofenac and 
pethidine groups in which drugs were directly injected in 
the sciatic nerve than in the saline group (p<0.05) (Table 
1). Furthermore, vacuolization was significantly higher in 
the diclofenac, morphine, and lornoxicam groups in which 
Pathological  ASaline (n) BMorphine (n) CPethidine (n) DDiclofenac (n) ELornoxicam (n) p
Changes Level
Myelin degeneration None 3 0 2 0 0
   +1 2 3 2 0 2 A-B p=0.032*
   +2 0 1 1 2 1 A-C p=0.419
   +3 0 1 0 3 2 A-D p=0.007**
   +4 0 0 0 0 0 A-E p=0.021*
Median (Min-Max)  0 (0-1) 1 (1-3) 1 (0-2) 3 (2-3) 2 (1-3)
Axon degeneration None 4 0 2 0 0
   +1 1 3 2 0 2 A-B p=0.014*
   +2 0 1 1 3 2 A-C p=0.189
   +3 0 1 0 2 1 A-D p=0.006**
   +4 0 0 0 0 0 A-E p=0.012*
Median (Min-Max)  0 (0-1) 1 (1-3) 1 (0-2) 2 (2-3) 2 (1-3) 
Epineurium degeneration None 4 0 0 0 0 A-B p=0.014*
   +1 1 3 3 0 3 A-C p=0.014*
   +2 0 2 2 4 2 A-D p=0.005**
   +3 0 0 0 1 0 A-E p=0.014*
Median (Min-Max)  0 (0-1) 1 (1-2) 1 (1-2) 2 (2-3) 1 (1-2) 
Fibrosis None 4 0 0 0 0 A-B p=0.015*
   +1 1 4 4 0 3 A-C p=0.015*
   +2 0 1 1 4 2 A-D p=0.005**
   +3 0 0 0 1 0 A-E p=0.014*
Median (Min-Max)  0 (0-1) 1 (1-2) 1 (1-2) 2 (2-3) 1 (1-2) 
Epineurium thickening None 4 0 0 0 1 A-B p=0.015*
   +1 1 4 3 0 3 A-C p=0.014*
   +2 0 0 1 2 1 A-D p=0.006**
   +3 0 1 1 3 0 A-E p=0.065
Median (Min-Max)  0 (0-1) 1 (1-3) 1 (1-3) 3 (2-3) 1 (0-2) 
Perineurium thickening None 3 1 2 0 0 A-B p=0.221
   +1 2 4 3 2 2 A-C p=0.549
   +2 0 0 0 3 2 A-D p=0.020*
   +3 0 0 0 0 1 A-E p=0.021*
Median (Min-Max)  0 (0-1) 1 (0-1) 1 (0-1) 2 (1-2) 2 (1-3) 
Lymphocyte infiltration None 2 0 0 0 0
   +1 3 4 3 0 0 A-B p=0.093
   +2 0 1 2 2 3 A-C p=0.058
   +3 0 0 0 3 2 A-D p=0.007**
   +4 0 0 0 0 0 A-E p=0.007**
Median (Min-Max)  0 (0-1) 1 (1-2) 1 (1-2) 3 (2-3) 2 (2-3) 
Vacuolisation None 3 0 1 0 0 A-B p=0.031*
   +1 2 3 3 0 1 A-C p=0.166
   +2 0 2 1 3 3 A-D p=0.007**
   +3 0 0 0 2 0 A-E p=0.013*
n: number of subjects with pathological changes, Mann–Whitney U test; * p<0.05, **p<0.01.
Table 2. The assessment of histopathological damage comparing saline with other drugs when the agents were injected in 
the muscle tissue adjacent to the sciatic nerve
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drugs were injected in the tissue adjacent to the sciatic 
nerve than in the saline groups (p<0.05) (Table 2). On 
comparing the different injection sites, the vacuolization 
in the diclofenac, morphine, pethidine, and saline groups 
was found to be significantly higher (p<0.05) (Table 3).
Edema
Edema in all the groups in which drugs were directly in-
jected in the sciatic nerve was significantly higher than 
that in the groups in which saline was injected (p<0.05) 
(Table 1). On comparing different injections in the tissue 
adjacent to the sciatic nerve, the diclofenac and lornoxi-
cam groups showed greater edema than the saline-in-
jected groups (p<0.05) (Table 2). The injection of di-
clofenac, morphine, and pethidine in the sciatic nerve 
causes higher edema than that in the tissue adjacent to 
the sciatic nerve (p<0.05) (Table 3). 
Anti-S100 positivity
The level of anti-s100 positivity was the highest in the 
saline group (p<0.05). It was the lowest in the diclofenac 
group.
DISCUSSION
The sciatic nerve is prone to injury following drug injec-
tion, and the proportion of sciatic nerve damage result-
ing from intramuscular injections is reported to be high 
(86% of all cases) [11]. Sciatic nerve damage arises from 
an injection either directly in the sciatic nerve or in the 
surrounding tissue [12–19]. Inappropriate drug injec-
tion in the gluteal region can result in direct damage to 
the sciatic nerve. The mechanism of injury appears to be 
a direct toxic effect of the injected compound on the neu-
ral tissue [12–20]. During injection in the sciatic nerve, 
the drug sometimes may get injected between the nerve 
and the sheath or between the fascicles. In these cases, 
neuronal damage occurs due to the effect of the drug 
rather than a physical damage to the nerve. Furthermore, 
the accumulation of the drug around the sciatic nerve 
or at an epineural level may result in sciatic nerve dam-
age [12–14, 20, 21]. The neurological defects following 
drug injection directly in the sciatic nerve are observed 
depending on the level of damage induced by the specific 
agent injected [14, 15]. In addition, the quantity of the 
drug injected is important in determining the degree of 
injury [18]. The most severe injuries are associated with 
widespread axon and myelin degeneration, and the patho-
logical alterations in the nerve are evident as early as 30 
min following the injury due to the injection [17, 18]. In 
their study investigating the toxic effect of non-steroidal 
anti-inflammatory drugs during development, Canan et 
al reported that axon loss was significantly prominent 
in rats exposed to diclofenac sodium [20]. In our study, 
we demonstrated that analgesic drug or saline injection 
directly in the sciatic nerve caused nerve damage. This 
result was similar to the report by Canan et al. [20]. The 
histopathological changes were most prominent in the 
diclofenac group and least prominent in the lornoxicam 
group, as shown in Table 1. The diclofenac group showed 
many types of pathological changes, including axon dam-
age in the subjects in which drugs or saline were injected 
in the tissue adjacent to the sciatic nerve, although the 
    Morphine Pethidine Diclofenac Lornoxicam Saline (SF)
Miyelin Degeneration 0.121 0.011* 0.031* 0.734 0.166
Axon Degeneration 0.356 0.007** 0.020* 0.74 0.065
Epineurium Degeneration 1.000 0.166 0.072 0.221 0.015*
Fibrosis  0.015* 0.007** 0.072 0.166 0.513
Epineurium Thickening 0.317 0.121 1.000 0.166 0.513
Perineurium Degeneration 0.093 0.017* 0.134 0.729 0.042*
Lymphocyte Infiltration 0.006** 0.007** 0.005** 0.513 0.093
Vacuolisation 0.042* 0.013* 0.011* 0.736 0.020*
Edema  0.005** 0.023* 0.005** 0.142 0.166
Mann Whitney U test; * p<0.05 **p<0.01.
Table 3. The comparison of histopathological damage after the injection of agents in the sciatic nerve and in the muscle 
tissue adjacent to the nerve
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other drug groups did not show any prominent findings 
related to the nerve damage (Table 2). All these findings 
supported the fact that nerve damage resulted from in-
jection either directly in the sciatic nerve or in the tissue 
adjacent to the nerve. As another important finding of 
our study, we have shown toxic effects of all the drugs, 
although we used the lowest dosages reported in the lit-
erature [7–10, 19].
The intramuscular use of diclofenac, lornoxicam, mor-
phine, and pethidine has been well established for the 
treatment of acute pain [22–31]. Among these, diclofenac 
and pethidine have both analgesic and anti-inflammatory 
effects [26–29]. Morphine and pethidine are narcotic 
drugs with analgesic effects [30, 31]. There is currently 
no report demonstrating the histopathological effects of 
diclofenac on the sciatic nerve, although diclofenac has 
been reported to induce anaphylaxis after intramuscular 
injection for acute pain treatment [28]. In our study, the 
histopathological changes observed with the injection of 
diclofenac in the sciatic nerve were more than those with 
the other drugs. Compared with other drugs, diclofenac 
induced more histopathological changes after injection in 
not only the sciatic nerve but also the tissue adjacent to 
the nerve. It is known that the protein level of S-100 de-
creases, and it can be demonstrated using immunohisto-
chemical staining when there is nerve damage [32]. In the 
present study, anti-s100 positivity, showing nerve dam-
age, was found to be the lowest in the diclofenac group 
with direct injection in the sciatic nerve. This observation 
indicates that diclofenac is the most toxic agent among 
the drugs injected in this study. Milder histopathologi-
cal changes were observed on evaluating the toxic effects 
of the other drugs. Lornoxicam seems to be one of the 
drugs that can be intramuscularly used for acute pain 
treatment, and there are no reports on sciatic nerve dam-
age induced by an intramuscular injection of this drug in 
the gluteal region or its histopathological effects on the 
sciatic nerve [24, 25]. Lornoxicam injection in the sci-
atic nerve resulted in greater damage supported based on 
the histopathological evidence, and anti-S100 positivity 
was detected to be lower in the lornoxicam group with 
injection in the sciatic nerve than in the control group 
with serum physiological injection in the sciatic nerve. 
This data suggests that the histopathological effects of 
lornoxicam on the sciatic nerve were more than those of 
serum physiological but milder than those of diclofenac.
Both morphine and pethidine are administered intra-
muscularly in the gluteal region for acute pain treatment 
[22, 29–31]. Morphine is a narcotic analgesic lacking 
anti-inflammatory properties and is known to suppress 
respiration at higher doses and to pose an addiction risk. 
[22]. In our study, the histopathological changes were 
more severe in the morphine and pethidine groups in 
which the drugs were directly injected in the sciatic nerve 
than in the groups in which these drugs were injected in 
the tissue adjacent to the nerve. The anti-S100 positivity 
was found to be lower in the groups in which morphine 
and pethidine were directly injected in the sciatic nerve 
than in the groups in which serum physiological was in-
jected. This proved the histopathological effects of mor-
phine and pethidine on the sciatic nerve; however, their 
effects were found to be milder than those of diclofenac. 
Compared with the other drug injections, pethidine in-
jection in the muscle tissue adjacent to the nerve resulted 
in less damage. Anti-S100 positivity in the group with 
pethidine injected in the sciatic nerve was found to be 
lower than that in the group injected with serum physi-
ological ; this supports the evidence for the histopatho-
logical effects of pethidine on the sciatic nerve. Moreover, 
the injection of pethidine resulted in minor histopatho-
logical changes compared with that of other drugs. To 
our knowledge, these are the first results of damage after 
direct injections in the sciatic nerve or the tissue adjacent 
to the nerve; thus, no laboratory or clinical study is avail-
able in the literature to compare our findings.
CONCLUSION
In conclusion, the site of injection is the most crucial fac-
tor in determining the degree of nerve injury. Most widely 
used analgesic drugs can easily induce damage-related 
changes in the sciatic nerve when the drug is directly in-
jected in the sciatic nerve or in the tissue adjacent to the 
sciatic nerve. Neurotoxic effects of diclofenac on the sciatic 
nerve were detected to be greater than those of other drugs 
used in the present study. Thus, we recommend that the 
use of diclofenac intramuscularly should be restricted in 
emergency units and even inpatient clinics. Additionally, 
lornoxicam, morphine, and pethidine have been demon-
strated to have neurotoxic effects on the sciatic nerve tissue 
despite lack of relevant studies. Lornoxicam, with anti-in-
flammatory effects, has also been shown to exert neuro-
toxic effects on the sciatic nerve, although its effects were 
the mildest. Furthermore, we suggest that intramuscular 
use of morphine and pethidine should be overviewed.
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